Susan Hasty, Publisher
Table of Contents . . . July 27th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Drug Development - Potential Cancer Therapy Is Based On A Natural Antibiotic
Mycobacteria - Moxifloxacin Beats Other Fluoroquinolones Against M. Fortuitum
Bone Loss - Blood Vessels Found To Signal Chain Of Destruction
Complementary and Alternative Medicine - ACOG Says "Buyer Beware" Of Botanical Treatments For Menopausal Symptoms
Drug Development - Chemists Synthesize Biologically Important Carbohydrate Molecules
Tuberculosis - Researchers Identify Critical Regulatory Gene
Cardiac Calcification - Side Effect Of Renal Disease Treatment Is Reduced By Drug
Diabetes - Combination Therapy Improves Blood Glucose Control
Diabetic Nephropathy - Irbesartan Protects Against Disease Progression
Drug Delivery - Company Says It Has Determined How Carrier Red Blood Cells Can Release Their Payload
Drug Development - Technology Expanded To Include Biologic Cancer Therapeutics
Erectile Dysfunction - Oral Vardenafil Effective For Men With Diabetes
Leukemia - Immunosuppressive Agent Pentostatin Shows Promise
Multiple Sclerosis - Interferon Alfa-n3 Reduces Brain Lesions
Multiple Sclerosis - Patients Benefit From High-Dose Interferon Therapy
Osteoporosis - Risedronate Provides Five-Year Fracture-Reduction Benefit
Psoriasis - Siplizumab Safe And Well Tolerated In Clinical Trials
Psoriasis - Topical Antisense Drug Penetrates And Reduces Plaque Thickness
Psoriasis - Trials Show Positive Results for/Sustained Relief After New Treatment
Renal Fibrosis - Collagen Inhibitor Significantly Reduces Fibrotic Process
Stroke - Catalytic Antioxidant Protects Brain Tissue
Type 2 Diabetes - Glimepiride Tablets Show Reduced Risk of Early Hypoglycemia
Type 2 Diabetes - Orlistat Helps Reduce Risk Factors
Type 2 Diabetes - Repaglinide Has Unique Mechanism Of Action
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.